EPIDEMIOLOGY AND HEALTH DATA INSIGHTS
Original Article
Feb 09, 2026 8 4

Prevalence, Incidence and Mortality of Thyroid Cancer in Kazakhstan: Data from the Unified National Electronic Health System 2014-2021

Ramina Abdymananova 1 * ,
Shamshyrak Aralbayeva 1,
Baknur Absattar 1,
Meruyert Ryskulbek 1,
Altynay Beyembetova 1,
Ayana Ablayeva 1,
Aigerim Biniyazova 1,
Diyora Abdukhakimova 1,
Abduzhappar Gaipov 1
1 Department of Medicine, Nazarbayev University School of Medicine, Astana, Kazakhstan* Corresponding Author
Epidemiology and Health Data Insights, 2(2), 2026, ehdo029, https://doi.org/10.63946/ehdi/17889
Publication date: Feb 09, 2026
Full Text (PDF)

ABSTRACT

Introduction: Thyroid cancer is one of the most common endocrine malignancies. According to global studies, its prevalence has been increasing worldwide and continues to grow. Although there have been global epidemiological studies on thyroid cancer, there is limited data on its epidemiology in Central Asian countries, including Kazakhstan.
Materials and Methods: A retrospective study utilized data from the Unified National Electronic Health System on thyroid cancer patients in Kazakhstan from 2014 to 2021. A descriptive analysis of patients was performed based on key demographic factors. Survival analysis was conducted using the Kaplan-Meier estimator and Cox proportional hazards regression.
Results: In total, 4,877 cases of thyroid cancer have been included during the period from 2014 to 2021 in Kazakhstan. Most of the diagnosed patients throughout the given period were females. The highest incidence and prevalence rates were found in the age group of 51-70 years old, while the highest mortality rate was among patients older than 70 years. Increasing age and male sex were the major predictors of mortality among thyroid cancer patients.
Conclusion: The obtained data coaligned with global data on thyroid cancer. Increased age, male sex, and living area were associated with poor prognosis. The study was limited by missing information on comorbidities and treatment types that the patients could have received. Therefore, further research is needed to assess the impact of such significant factors on survival.

KEYWORDS

Thyroid Cancer Kazakhstan Incidence Prevalence Survival Analysis Retrospective Studies

CITATION (Vancouver)

Abdymananova R, Aralbayeva S, Absattar B, Ryskulbek M, Beyembetova A, Ablayeva A, et al. Prevalence, Incidence and Mortality of Thyroid Cancer in Kazakhstan: Data from the Unified National Electronic Health System 2014-2021. Epidemiology and Health Data Insights. 2026;2(2):ehdo029. https://doi.org/10.63946/ehdi/17889
APA
Abdymananova, R., Aralbayeva, S., Absattar, B., Ryskulbek, M., Beyembetova, A., Ablayeva, A., Biniyazova, A., Abdukhakimova, D., & Gaipov, A. (2026). Prevalence, Incidence and Mortality of Thyroid Cancer in Kazakhstan: Data from the Unified National Electronic Health System 2014-2021. Epidemiology and Health Data Insights, 2(2), ehdo029. https://doi.org/10.63946/ehdi/17889
Harvard
Abdymananova, R., Aralbayeva, S., Absattar, B., Ryskulbek, M., Beyembetova, A., Ablayeva, A., . . . Gaipov, A. (2026). Prevalence, Incidence and Mortality of Thyroid Cancer in Kazakhstan: Data from the Unified National Electronic Health System 2014-2021. Epidemiology and Health Data Insights, 2(2), ehdo029. https://doi.org/10.63946/ehdi/17889
AMA
Abdymananova R, Aralbayeva S, Absattar B, et al. Prevalence, Incidence and Mortality of Thyroid Cancer in Kazakhstan: Data from the Unified National Electronic Health System 2014-2021. Epidemiology and Health Data Insights. 2026;2(2), ehdo029. https://doi.org/10.63946/ehdi/17889
Chicago
Abdymananova, Ramina, Shamshyrak Aralbayeva, Baknur Absattar, Meruyert Ryskulbek, Altynay Beyembetova, Ayana Ablayeva, Aigerim Biniyazova, Diyora Abdukhakimova, and Abduzhappar Gaipov. "Prevalence, Incidence and Mortality of Thyroid Cancer in Kazakhstan: Data from the Unified National Electronic Health System 2014-2021". Epidemiology and Health Data Insights 2026 2 no. 2 (2026): ehdo029. https://doi.org/10.63946/ehdi/17889
MLA
Abdymananova, Ramina et al. "Prevalence, Incidence and Mortality of Thyroid Cancer in Kazakhstan: Data from the Unified National Electronic Health System 2014-2021". Epidemiology and Health Data Insights, vol. 2, no. 2, 2026, ehdo029. https://doi.org/10.63946/ehdi/17889

REFERENCES

  1. Hiller-Sturmhöfel S, Bartke A. The Endocrine System (Overview). Alcohol Health Res World. 1998;22(3):153–64.
  2. Khodamoradi F, Ghoncheh M, Mehri A, Hassanipour S, Salehiniya H. Incidence, mortality, and risk factors of thyroid cancer in the world: a review. World Cancer Res J. 2018;5(2):e1093. DOI: 10.32113/wcrj_20186_1093
  3. Bao W, Zi H, Yuan Q, Li L, Deng T. Global burden of thyroid cancer and its attributable risk factors in 204 countries and territories from 1990 to 2019. Thorac Cancer. 2021 Aug 5;12(18):2494–503. DOI: 10.1111/1759-7714.14099
  4. Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022 Mar;10(4):264–72. DOI: 10.1016/S2213-8587(22)00035-3
  5. Igissinov N, Kozhakhmetov S, Zhantubetova M, Igissinova G, Bilyalova Z, Akpolatova G. Thyroid Cancer in Kazakhstan: Component Analysis of Incidence Dynamics. Asian Pac J Cancer Prev. 2019 Sep 1;20(9):2875–80. DOI: 10.31557/APJCP.2019.20.9.2875
  6. Arynova Z, Baiguzhinova L. Development of electronic healthcare in Kazakhstan as a factor of improving the quality of medical services. Fundam Appl Res Pract Lead Sci Sch. 2019 Feb 28;31(1):3–6. DOI: 10.33531/farplss.2019.1.01
  7. Beyembetova A, Ablayeva A, Akhmedullin R, Abdukhakimova D, Biniyazova A, Gaipov A. National Electronic Oncology Registry in Kazakhstan: Patient’s Journey. Epidemiol Health Data Insights. 2025 May 17;1(1):ehdi004–4. DOI: 10.63946/ehdi/16385
  8. Assan A, Zhakhina G, Kerimbayeva Z, Moldaliyev I, Sychev D, Tuganbekova S, et al. Epidemiology of glomerular diseases in Kazakhstan during the period of 2014-2019: data from the Unified national electronic healthcare system. J Clin Med Kaзахстана. 2024 Feb 25;21(1):55–60. DOI: 10.23950/jcmk/14270
  9. Syssoyev D, Seitkamzin A, Lim N, Mussina K, Poddighe D, Gaipov A, et al. Epidemiology of Congenital Heart Disease in Kazakhstan: Data from the Unified National Electronic Healthcare System 2014-2021. J Clin Med Kaзахстана. 2024 Jun 10; DOI: 10.23950/jcmk/14683
  10. Midlenko A, Mussina K, Zhakhina G, Sakko Y, Rashidova G, Saktashev B, Adilbay D, Shatkovskaya O, Gaipov A. Prevalence, incidence, and mortality rates of breast cancer in Kazakhstan: data from the Unified National Electronic Health System, 2014-2019. Front Public Health. 2023 Apr 17;11:1132742. DOI: 10.3389/fpubh.2023.1132742
  11. Kuijpens JLP, Janssen-Heijnen MLG, Lemmens VEPP, Haak HR, Heijckmann AC, Coebergh JWW. Comorbidity in newly diagnosed thyroid cancer patients: a population-based study on prevalence and the impact on treatment and survival. Clin Endocrinol (Oxf). 2006 Apr;64(4):450–5. DOI: 10.1111/j.1365-2265.2006.02492.x
  12. Akhmedullin R, Aimyshev T, Zhakhina G, Yerdessov S, Beyembetova A, Ablayeva A, et al. In-depth analysis and trends of cancer mortality in Kazakhstan: a joinpoint analysis of nationwide healthcare data 2014–2022. BMC Cancer. 2024 Oct 31;24(1). [DOI not yet available for this newly published article; please check the journal's website].
  13. Pérez C, León P, González S, et al. Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res. 2015;8:20. DOI: 10.1186/s13044-015-0020-8

LICENSE

Creative Commons License
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.